Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
- H. Burris, M. Moore, D. V. Von Hoff
- MedicineJournal of clinical oncology : official journal…
- 1 June 1997
TLDR
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
- D. V. Von Hoff, T. Ervin, M. Renschler
- Medicine, BiologyThe New England journal of medicine
- 30 October 2013
TLDR
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
- P. Provenzano, C. Cuevas, Amy E Chang, V. Goel, D. V. Von Hoff, S. Hingorani
- BiologyCancer cell
- 20 March 2012
Risk factors for doxorubicin-induced congestive heart failure.
- D. V. Von Hoff, M. Layard, F. Muggia
- MedicineAnnals of internal medicine
- 1 November 1979
TLDR
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.
- D. V. Von Hoff, P. LoRusso, J. Low
- MedicineThe New England journal of medicine
- 10 December 2009
TLDR
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
- D. V. Von Hoff, R. Ramanathan, M. Hidalgo
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 December 2011
TLDR
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
- M. Hidalgo, L. Siu, E. Rowinsky
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 July 2001
TLDR
Hypersensitivity reactions from taxol.
- R. Weiss, R. Donehower, B. Leyland-Jones
- MedicineJournal of clinical oncology : official journal…
- 1 July 1990
TLDR
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
- D. V. Von Hoff, J. Stephenson, R. Penny
- Medicine, BiologyJournal of clinical oncology : official journal…
- 20 November 2010
TLDR
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
TLDR
...
...